Oura Ring 5 Price and Blood Pressure Signals: What $399 Actually Buys You
The Oura Ring 5 starts at $399 and ships with overnight blood pressure signals. It is not FDA cleared, and the reason why is a rule change most coverage skipped.
Signal Ring Blood Pressure Wearable: What the $399 Ring Actually Does
Signal Ring promises cuffless, calibration-free blood-pressure readings from a $399 titanium ring. Here is what it does, what the evidence shows, its FDA status, and what remains unproven.
The Protein Paradox: Why Less May Mean More for Longevity
A sweeping review of 350 studies says the protein supplement boom may be overselling something most sedentary adults do not actually need, and that eating less of it could activate…
The FDA’s New AI Experiment Asks a Better Question: Did the Patient Get Better?
The FDA and CMS are testing a new bridge from AI-enabled chronic-care technology to Medicare payment, real-world evidence, and measurable patient outcomes. The promise is real. The proof is not…
The Scan Found a Lung Nodule. Then the Hospital Had to Find the Patient.
A new emergency-department study shows where healthcare AI can matter: not simply spotting a signal, but helping a care team contact the patient and complete the next step.
The Gut-Joint Axis Proves Its Case: A Daily Fiber Supplement Reduced Knee Arthritis Pain in Six Weeks
A randomized controlled trial from the University of Nottingham has delivered a striking result: a simple, daily prebiotic fiber supplement reduced knee osteoarthritis pain in six weeks, rivaled the effects…
Hilo Core Blood Pressure Wearable: What the U.S. System Actually Does
Hilo Core brings Aktiia’s optical blood-pressure technology to the United States in a $239.98 first-year system. The wristband is a wellness trend tool, while exact reference readings come from the…
Healthcare Delivery Venture Capital: Why Closing the Last Mile Creates Value
Healthcare delivery creates venture-scale value when access, clinical operations, evidence, reimbursement, and unit economics combine to close the last mile of care.
Generative Biology: The New Healthcare Venture Capital Stack
Generative biology connects foundation models, proprietary experimental data, automated laboratories, therapeutic assets, manufacturing, and clinical translation into a new healthcare venture-capital stack.
AI in Healthcare Venture Capital: Where the Durable Moats Are Forming
Healthcare AI models are becoming cheaper and more accessible. The durable venture moats are forming around workflow ownership, proprietary learning data, evidence, regulation, distribution, measurable economics, and platform expansion.
